Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
BCMA CAR-T 治疗后的绝对淋巴细胞计数可预测复发性多发性骨髓瘤的疗效和预后
期刊:Blood Advances
影响因子:7.4
doi:10.1182/bloodadvances.2023012470
Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, Tarek H Mouhieddine, Juan Esteban Velez-Hernandez, Katherine Engles, Joshua A Fein, Jorge Monge, Cara Rosenbaum, Roger Pearse, David Jayabalan, Christian Gordillo, Hei Ton Chan, Samuel Yamshon, Santiago Thibaud, Markus Mapara, Giorgio Inghirami